Alik Farber, MD
Professor
Boston University School of Medicine
Dept of Surgery
Vascular and Endovascular Surgery

MD, Harvard Medical School




Dr. Farber is a graduate of Brown University and obtained his medical degree from Harvard Medical School. He completed a residency in general surgery at Massachusetts General Hospital; a vascular surgery fellowship at Dartmouth-Hitchcock Medical Center; and an endovascular surgery fellowship at the Southern Illinois School of Medicine. In addition to his role as Division Chief of Vascular and Endovascular Surgery, Dr. Farber is also Medical Director of BMC’s Catheterization and Angiography Laboratories and Co-Director of BMC’s Vascular Non-invasive Laboratory as well as Associate Chair for Clinical Operations in the Department of Surgery. He is a fellow in the American College of Surgeons and is a member of the American Board of Surgery. He is a member of many national and regional medical and surgical societies, including the Society for Vascular Surgery, where he was elected to distinguished fellow status in 2013, the Society of University Surgeons, the Western Vascular Surgery Society, the New England Society for Vascular Surgery, the International Society for Endovascular Surgery, and the Society for Clinical Vascular Surgery. Dr. Farber has served as a principal investigator in a number of clinical trials and is currently a National Co-Chair of the BEST-CLI Trial (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia), a $25 million grant awarded by the National Institutes of Health (NIH), to conduct a four-year, randomized clinical trial comparing traditional bypass surgery with the less invasive alternative of endovascular treatment for patients with critical limb ischemia (CLI). He has written and published many articles about vascular and endovascular surgery, has served as a moderator for various vascular meetings, and developed a formal education program in vascular surgery while at Cedar-Sinai Medical Center in Los Angeles, CA, which resulted in the Golden Apple Teaching Award for teaching and mentoring residents. Since his arrival at BMC, Dr. Farber has made it his goal and mission to foster continued clinical excellence and academic productivity. He is currently the director of a fourth year medical school elective (BMC Surgery Bootcamp) which is designed to prepare medical students who are going into surgical internship.

Section Chief
Boston University School of Medicine
Surgery
Vascular and Endovascular Surgery

Professor
Boston University School of Medicine
Radiology
Vascular & Interventional

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research




A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols
05/01/2012 - 12/31/2015 (PI)
Grifols Inc


A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm^2 to <= 36 cm^2
10/15/2013 - 08/30/2015 (PI)
HealthPoint Limited


A Non-Interventional Safety Study Providing 12 Months Follow-Up from First Exposure to HP802-247 in Subjects with Venous Leg Ulcer
05/01/2012 - 04/30/2015 (PI)
HealthPoint Limited


Observational Study of Tissue Plasminogen Activator Used for Catheter Directed Thrombolysis in Patients with Acute Lower Extremety Native Artery or Bypass Graft Occlusion
01/27/2014 - 01/26/2015 (PI)
Grifols Inc


A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
05/01/2012 - 04/30/2014 (PI)
HealthPoint Limited


Vital Access Venous Window Needle Guide for salvage of AV Fistulae (SAVE) Trial
08/15/2012 - 08/14/2013 (PI)
Vital Access Corp


IN-BALANCE VLU (Inflammation, Bacteria, and Angiogenesis effects in launching venous leg ulcer healing: a clinical evaluation)
08/01/2012 - 07/31/2013 (PI)
Celleration, Inc.


A Phase 2 randomized open label study to evaluate the effects of different intra-thrombus infusion regiments of plasmin humun compared to placebo
08/01/2011 - 07/31/2012 (PI)
Talecris Pharmaceuticals


A Phase 2 randomized open label study to evaluate the effects of different intra-thrombus infusion regiments of plasmin humun compared to placebo
08/01/2011 - 07/31/2012 (PI)
Talecris Pharmaceuticals


A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
08/01/2009 - 12/31/2011 (PI)
HealthPoint Limited


Showing 10 of 16 results. Show All Results

Natural Progression of High-Risk Chronic Limb-Threatening Ischemia. The CLariTI Study.
03/25/2021 - 03/25/2024 (PI)
LimFlow Inc

A Pivotal Study to Investigate the Safety and Effectiveness of the Limflow System for the…
12/11/2019 - 12/11/2022 (PI)
LimFlow Inc

A multicenter, prospective, randomized, placebo controlled, double blind study performed to…
09/24/2019 - 09/23/2022 (PI)
MediWound LTD.

BEST-CLI Trial-CCC-Lead
09/17/2013 - 03/31/2021 (PI)
Brigham & Women's NIH-NHLBI
5U01HL107352-05

A multi-center prospective study to evaluate the safety and effectiveness of the VasQ external suppo
11/01/2017 - 11/01/2020 (PI)
Laminate Medical Technologies Inc.

Dose-response relationship study of S42909 on leg ulcer healing after oral repeated administration..
08/06/2018 - 06/01/2019 (PI)
Ilkos Therapeutic Inc

RANGER
06/19/2017 - 06/01/2019 (PI)
Boston Scientific Corporation

Randomized Trial Comparing a Dual Action Pneumatic Compression System against Multi-Layer Bandagi…
06/15/2016 - 06/14/2018 (PI)
ACTitouch Medical

Open versus Endovascular Popliteal Artery Aneurysm (OVER-PAR) Repair Trial
11/01/2013 - 06/30/2017 (PI)
New England Society for Vascular Surgery

A Phase-3 Study of Curexcell
12/04/2014 - 12/31/2016 (PI)
Macro Cure Ltd.

Showing 10 of 13 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Siracuse JJ, Goodney PP, Menard MT, Rosenfield K, Van Over M, Hamza TH, Eid M, Villarreal MF, Strong MB, Farber A. Participation in a Chronic Limb Threatening Ischemia Randomized Trial Is Inversely Correlated With Regional Amputation Rate in Limb Threatening Ischemia Patients. Ann Surg. 2021 10 01; 274(4):621-626.View Related Profiles. PMID: 34506317
     
  2. Huber TS, Berceli SA, Scali ST, Neal D, Anderson EM, Allon M, Cheung AK, Dember LM, Himmelfarb J, Roy-Chaudhury P, Vazquez MA, Alpers CE, Robbin ML, Imrey PB, Beck GJ, Farber AM, Kaufman JS, Kraiss LW, Vongpatanasin W, Kusek JW, Feldman HI. Arteriovenous Fistula Maturation, Functional Patency, and Intervention Rates. JAMA Surg. 2021 Sep 22. PMID: 34550312
     
  3. Arinze N, Farber A, Levin SR, Cheng TW, Rybin D, Siracuse JJ. The Association of Body Mass Index with Outcomes after Carotid Endarterectomy. Ann Vasc Surg. 2021 Aug 23.View Related Profiles. PMID: 34437970
     
  4. McGinigle KL, Freeman NLB, Marston WA, Farber A, Conte MS, Kosorok MR, Kalbaugh CA. Precision Medicine Enables More TNM-Like Staging in Patients With Chronic Limb Threatening Ischemia. Front Cardiovasc Med. 2021; 8:709904. PMID: 34336963; PMCID: PMC8322654; DOI: 10.3389/fcvm.2021.709904;
     
  5. Haqqani MH, Levin SR, Kalish JA, Brahmbhatt TS, Richman AP, Siracuse JJ, Farber A, Jones DW. High Mortality and Venous Thromboembolism Risk Following Major Penetrating Abdominal Venous Injuries. Ann Vasc Surg. 2021 Jun 19.View Related Profiles. PMID: 34153491
     
  6. Beuschel B, Nayfeh T, Kunbaz A, Haddad A, Alzuabi M, Vindhyal S, Farber A, Murad MH. A systematic review and meta-analysis of treatment and natural history of popliteal artery aneurysms. J Vasc Surg. 2021 May 29. PMID: 34058308
     
  7. Farber A, Angle N, Avgerinos E, Dubois L, Eslami M, Geraghty P, Haurani M, Jim J, Ketteler E, Pulli R, Siracuse JJ, Murad MH. The Society for Vascular Surgery clinical practice guidelines on popliteal artery aneurysms. J Vasc Surg. 2021 May 20.View Related Profiles. PMID: 34023430
     
  8. Dakour-Aridi H, Malas MB, Farber A, Avgerinos ED, Eslami MH. Association of Medicaid Expansion with In-Hospital Outcomes After Abdominal Aortic Aneurysm Repair. J Surg Res. 2021 10; 266:201-212. PMID: 34022654
     
  9. Cheng TW, Farber A, Levin SR, Malas MB, Garg K, Patel VI, Kayssi A, Rybin D, Hasley RB, Siracuse JJ. Perioperative Outcomes for Centers Routinely Admitting Postoperative Endovascular Aortic Aneurysm Repair to the ICU. J Am Coll Surg. 2021 06; 232(6):856-863.View Related Profiles. PMID: 33887484
     
  10. Albaghdadi MS, Young MN, Chowdhury MM, Assmann S, Hamza T, Siami S, Villarreal M, Strong M, Menard M, Farber A, Rosenfield K. Clinical practice patterns and ascertainment bias for cardiovascular events in a randomized trial: A survey of investigators in the BEST-CLI trial. Vasc Med. 2021 Apr; 26(2):180-186. PMID: 33825577
     
Showing 10 of 303 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 302 publications over 23 distinct years, with a maximum of 41 publications in 2016

YearPublications
19921
19931
19992
20011
20022
20033
20044
20051
20073
20082
20096
20104
201112
20129
201319
201415
201521
201641
201738
201840
201925
202036
202116

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
Contact for Mentoring:

75 E. Newton St Collamore Building
Boston MA 02118
Google Map


Farber's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department